It is widely accepted that vertebrate G-Protein Coupled Receptors (GPCRs) associate with each other as homo- or hetero-dimers or higher-order oligomers. The C. elegans genome encodes hundreds of olfactory GPCRs, which may be expressed in fewer than a dozen chemosensory neurons, suggesting an opportunity for oligomerisation. Here we show, using three independent lines of evidence: co-immunoprecipitation, bioluminescence resonance energy transfer and a yeast two-hybrid assay that nematode olfactory receptors (ORs) oligomerise when heterologously expressed in yeast. Specifically, the nematode receptor ODR-10 is able to homo-oligomerise and can also form heteromers with the related nematode receptor STR-112. ODR-10 also oligomerised with the rat I7 OR but did not oligomerise with the human somatostatin receptor 5, a neuropeptide receptor. In this study, the question of functional relevance was not addressed and remains to be investigated.
Citation: Tehseen M, Liao C, Dacres H, Dumancic M, Trowell S, Anderson A (2014) Oligomerisation of C. elegans Olfactory Receptors, ODR-10 and STR-112, in Yeast. PLoS ONE 9(9): e108680. https://doi.org/10.1371/journal.pone.0108680
Editor: Johannes Reisert, Monell Chemical Senses Center, United States of America
Received: January 22, 2014; Accepted: September 2, 2014; Published: September 25, 2014
Copyright: © 2014 Tehseen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The research is funded by CSIRO. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
G-protein coupled receptors (GPCRs) are the largest and most diverse superfamily of proteins and are present in every eukaryotic cell . They are involved in the senses of vision, smell, taste, pain, cell recognition and communication processes. GPCRs are characterised structurally by an amino-terminal extracellular domain, a carboxyl-terminal intracellular domain and seven hydrophobic transmembrane domains. They are activated by a wide variety of ligands, including peptide and non-peptide neurotransmitters, hormones, growth factors and odorant molecules and are encoded by the largest gene family in most animal genomes. For example, 1% of the total genes in Drosophila, ∼4% of all genes in the human genome and >5% of all genes in Caenorhabditis elegans encode GPCRs .
GPCRs were once thought to act as monomers but in the last decade evidence has emerged that the primary signalling unit consists of homo- or heterodimers –. GPCR oligomerisation is also important for receptor maturation, trafficking, agonist specificity and signalling , . The potential diversity of GPCR heterodimers can increase the repertoire of GPCR recognition and signalling via allosteric mechanisms , . For example, surface expression of α2C- and α1D-adrenergic receptors is greatly enhanced by co-expression of β2-adrenergic receptors –, while the GABAB receptor subunits R1 and R2 associate, through their cytoplasmic tails, in the endoplasmic reticulum and are targeted to the plasma membrane as a preformed dimer, independent of agonist regulation . It has been shown that hetero-oligomerisation can either inhibit or facilitate endocytosis and affect receptor signalling , . For example, hetero-oligomerisation between the beta-1 adrenergic receptor (β1-AR), which is poorly internalised, and the β2-AR, which is strongly internalised, results in inhibition of agonist-promoted internalisation of the latter.
Although evidence for GPCR hetero-oligomerisation is mostly drawn from studies on a few, well-characterised vertebrate receptors for hormones and neurotransmitters, the largest families of GPCRs are involved in chemoreception. Vertebrate olfaction and taste perception (sweet, bitter and umami)  depend on GPCRs, as does chemosensation in nematodes. Vertebrate olfactory receptors generally conform to the one receptor type per Olfactory Sensory Neuron model , . Mammalian sweet and umami taste receptors function as heterodimers , . Nematode olfactory receptors pose an interesting dilemma because the genome of the free-living nematode, C. elegans, encodes >1300 GPCRs, many of which are believed to be chemoreceptors . These receptors respond to many volatile odorants, but despite the large number of receptors, the nematode has only three pairs of olfactory neurons and only 32 pairs of chemosensory neurons in total , . This inevitably requires that multiple types of chemoreceptor pairs are co-expressed in individual neurons , . The question arises as to whether homo- or hetero-oligomerisation of nematode chemoreceptors can occur and if it does, whether it has any functional relevance in relation to chemoreceptor function, including ligand specificity.
So far, in C. elegans, only one GPCR, ODR-10, has been experimentally linked to olfaction. ODR-10 is a member of the str family of GPCRs, and is expressed predominantly in the AWA neuron pair , . ODR-10 mediates chemotaxis towards diacetyl, a volatile ligand , . We set out to investigate whether ODR-10 can form homo-oligomers or hetero-oligomers with other putative chemosensory GPCRs.
GPCR homo- and hetero-oligomers have previously been identified using various techniques such as bioluminescence resonance energy transfer (BRET), fluorescence resonance energy transfer (FRET), cross linking-studies and co-immunoprecipitation –. In this study we use the split-ubiquitin yeast two-hybrid system as well as BRET and co-immunoprecipitation to investigate potential homo- and hetero-oligomerisation of the C. elegans odorant receptor, ODR-10. We provide the first direct evidence that a nematode chemoreceptor (ODR-10) homo-oligomerises and can also form hetero-oligomers with STR-112, a nematode GPCR closely related by sequence, and the rat I7 odorant receptor, but not with the human somatostatin receptor 5 (SSTR5), a neuropeptide receptor. It is unknown whether such heteromerisation, in the distinctly unnatural environment of a yeast cell, is replicated or could have any functional significance in vivo.
Materials and Methods
Yeast transformants expressing ODR-10-GFP2 were grown in selective dropout (SD) medium without histidine at 30°C overnight and the cells were inoculated into 10 ml of the same medium to give an initial absorbance at 600 nm (Abs600) = 0.025. The cells were again grown at 30°C overnight on a rotary shaker at 180 rpm. For microscopy, a 20 µL drop of yeast culture was placed on a clean glass slide and stained with 0.01% Evans Blue (Sigma) in culture medium, for 1min, covered with a cover slip and observed with a Leica SP2 confocal microscope (Germany) with 488 nm excitation, imaged at 510 nm for GFP2 emission and 660 nm for Evans Blue emission.
Plasmid construction and transformation for immunoprecipitation and BRET
Odr-10 was amplified by PCR from C. elegans cDNA prepared by standard techniques. Rat I7 receptor was amplified by PCR from the plasmid pCA4-I7-IRES-GFP, kindly provided by Prof S. Firestein . SSTR5 receptor was amplified by PCR from the plasmid pGK-SSTR5-HA, kindly provided by Dr Jun Ishii . The BRET tags Rluc and GFP2 were sourced from the plasmid pGFP2-MCS-Rluc(h) (Perkin Elmer) and introduced at the C-termini of odr-10, I7 and sstr5, by PCR amplification as described previously . All clones were verified by sequencing and cloned into pDONR201 (Invitrogen) using attB sites introduced by PCR. BRET-labelled odorant receptors were transferred into pYES-DEST52 (Invitrogen) or pDEST ESC-TRP by Gateway (Invitrogen) recombination for expression in S. cerevisiae. The vector pDEST ESC-TRP was constructed by introducing a 1.4 kb Gateway attR1-ccdB-attR2 cassette (Invitrogen) into the XhoI site of pESC-TRP (Stratagene), downstream of the GAL1 promoter, using standard techniques. The plasmid pYES-DEST52 confers uracil selection in S. cerevisiae and pDEST ESC-TRP confers tryptophan selection. The two plasmids were transformed into S. cerevisiae strain InvSc1 (Invitrogen) either individually or in combination. Transformed yeast colonies were screened by PCR to confirm the presence of transgenes.
Transformants culture and tagged-gene induction conditions
Yeast strains were transformed using the lithium acetate method . Yeast was grown in a YPD medium [containing 1% yeast extract, 2% peptone and 2% glucose] or an SD medium [containing 0.67% yeast nitrogen base without amino acids and 2% glucose]. The SD medium was supplemented with appropriate amino acids depending on the selectable marker used. For solid media, 2% agar was added to the liquid media described above. In order to induce expression from the GAL1 promoter, glucose was replaced with 1% raffinose and 2% galactose.
After overnight culture at 28°C, Abs600nm was determined and cells were resuspended in induction medium to a final Abs600nm of 0.4. This culture was incubated for varying times, with shaking at 15°C, to induce expression of receptor fusions. To test whether interactions between tagged receptors were specific or simply due to collisional interactions at high receptor density, Rluc and GFP2 labelled receptors were co-expressed in InvSc1 and induced for different times (0, 4, 8, 16, 24, 48 and 72 hrs) in order to generate total fluorescence levels up to 12-fold higher than untransformed cells. Total cell fluorescence was measured at different induction times in 100 µl (12.5 fold concentrate of cell sample with Abs600nm = 0.4). Induction was stopped once the total fluorescence of the cells reached 1.2–2 fold higher than untransformed cells. Induced samples were pelleted and washed twice with cold phosphate-buffered saline (PBS). Induced cell suspensions were frozen as 12.5 fold concentrates in PBS, stored at −80°C and thawed in ice before assays.
Cell lysates were prepared as described previously  using a French Press (∼18000 psi) in buffer B [75 mM tris-HCl, pH7.4, 12 mM MgCl2 and 2 mM EDTA, protease inhibitor cocktail EASYpack (Roche Applied Science)]. Cellular debris was removed by centrifugation at 15,000 rpm for 15 mins at 4°C and membranes were collected by ultracentrifugation of the supernatant at 40,000 rpm for 60 min at 4°C. Pellets containing membranes were re-suspended in ice-cold buffer B and left at 4°C overnight to resuspend completely. Membrane suspensions were solubilised using 1% digitonin in buffer B with a detergent/protein ratio of approximately 1∶1. The mixture was mixed gently for 3 hrs at 4°C and then centrifuged at 18,000 g for 30 mins at 4°C to remove insoluble material. The digitonin concentration was adjusted to 0.2%. An equivalent number of cells were processed for all immunoprecipitation reactions.
Immunoprecipitation procedures were modified from . The luciferase activity of each sample was measured and reactions were standardised to equal luciferase activity. Polyclonal anti-green fluorescence protein antibody from rabbit (Sapphire Bioscience) was added to a final concentration of 0.001% (v/v) of serum. Immune complex formation was allowed to proceed overnight at 4°C with gentle agitation. Protein A-agarose (10% (w/v) Sigma) was added prior to a further 6 hr incubation. The agarose beads were sedimented by centrifugation at 5000 g for 3 mins at 4°C and were washed four times with ice-cold buffer B containing 0.2% digitonin. The luciferase activity of the beads was assessed using 5 µM coelenterazine H as substrate and an emission filter of 475±30 nm. Three independent yeast transformants were picked and each was processed and measured in triplicate. Data are presented as the mean percentage of maximal luciferase activity across all nine measurements.
Quantification of yeast cells for BRET2 assay
All yeast cultures were adjusted to the same density (100 µl/well of Abs600nm = 0.4, typically requiring 25 ml of culture resuspended in 2 ml of PBS buffer). All yeast strains expressing either receptor-GFP2, or receptor-Rluc and receptor-GFP2, fusion proteins were quantified by measuring the GFP2 fluorescence of 100 µl of Abs600nm = 0.4. GFP2 fluorescence was measured in a SpectraMax M2 spectrofluorometer (Molecular Devices), with excitation centred at 420 nm and an emission filter of 510 nm, in a 96-well white Optiplate (Perkin Elmer). Fluorescence was expressed relative to the background determined in wells containing the same number of untransformed cells. Luminescence was measured by adding Coelenterazine H to a final concentration of 5 µM, using an emission filter of 475 nm in a lumino/fluorometer microplate reader (Polarstar Optima, BMGLabtech).
Microplate BRET2 cell based assay
The assay, modified from Issad and Jockers , was conducted in duplicate in a 96-well white Optiplate in a total volume of 100 µl. Three independent transformants were processed and the data were pooled. Coelenterazine (DeepBlueC, Biosynth AG) was added to a final concentration of 10 µM, and readings were performed using a Polarstar Optima (BMGLabtech). Negative controls were: the host strain expressing ODR-10-Rluc/SSTR5-GFP2; the host strain expressing Rluc/GFP2; a mixture of the strain expressing ODR-10-Rluc only and the strain expressing ODR-10-GFP2 only. Rluc light emission was measured at 410±80 nm and GFP2 light emission at 515±30 nm. The BRET2 ratio is defined as the ratio of the emission intensities at 515 nm and 410 nm. Subtraction of the auto-fluorescence from all tested samples was undertaken before BRET ratio values were calculated.
Protein-protein interaction assays using split-ubiquitin membrane yeast two-hybrid system
The split-ubiquitin system  was used to investigate the interactions among ODR-10, I7, SSTR5 and STR-112 GPCRs. Vectors and yeast strain were as supplied in the DUALmembrane pairwise interaction kit (Dualsystems Biotech, Zürich, Switzerland). Full-length cDNAs of ODR-10, I7 and STR-112 were cloned into the pBT3-STE plasmid encoding the C-terminal half of ubiquitin (Cub) such that it was fused to the C-terminus of the GPCR and pPR3-STE encoding the mutated N-terminal half of ubiquitin (NubG) such that it was fused to the C-terminus of the GPCR. All cDNAs were cloned into Sfi I restriction sites. cDNA sequences were confirmed by DNA sequencing. Cub and NubG fusion constructs were co-transformed into the yeast strain NMY51. Interaction was determined by assessing the growth of yeast transformants on medium lacking histidine and confirmed by β-galactosidase assay (HTX Kit: Dualsystems Biotech, Zürich, Switzerland).
Results and Discussion
Localisation of nematode GFP2 fluorescent-tagged ODR-10 in yeast
We chose to express nematode receptor constructs in Saccharomyces cerevisiae because there is extensive literature showing that yeast can be used to functionally express GPCRs –, including the nematode chemoreceptor ODR-10 .
To observe the subcellular localisation of the ODR-10 receptor in yeast, a GFP2 fluorescent tag was introduced at its C-terminus. Yeast cells expressing ODR-10-GFP2 were examined by confocal microscopy. In yeast cells co-expressing ODR-10-GFP2 and ODR-10-Rluc, ODR-10-GFP2 was localised to the plasma membrane in ≈32% of cells after a 4 hour induction (Figure 1). Although some of ODR-10 was localised to the yeast plasma membrane, much of it was localised intracellularly (Figure 1), which has also previously been observed for mammalian chemoreceptors , , . However, it has also been shown that mammalian olfactory receptors are functional whether they are localised to yeast ER, Golgi or plasma membrane when tested in vitro , , . Based on these previous reports, we believe it is reasonable to infer that ODR-10 is correctly folded whether it is located in the plasma or intracellular membranes .
ODR-10 forms homo-oligomers
We tested for homo-oligomerisation of ODR-10 using three different methods; co-immunoprecipitation, bioluminescence resonance energy transfer (BRET) and the split-ubiquitin yeast two-hybrid system. Co-immunoprecipitation has been used extensively as a biochemical test for GPCR oligomerisation –. We co-expressed an Rluc-tagged receptor (ODR-10-Rluc) and a GFP2-tagged receptor (ODR-10-GFP2). Rluc-labelled ODR-10, co-expressed with GFP2-labelled ODR-10 was pulled down by anti-GFP antibody, as evidenced by a high level of co-immunoprecipitated luciferase activity (Figure 2A). Control immunoprecipitates containing untransformed yeast cells, Rluc co-expressed with GFP2, or a mixture of separately expressed ODR-10-GFP2 and ODR-10-Rluc, all showed approximately 20% of the total luminescence of the co-expressed receptor pairs (Figure 2A). We also co-expressed ODR-10-Rluc with SSTR5-GFP2, as a negative control, and this also showed approximately 20% of the total luminescence of the co-expressed receptor pairs (Figure 2B). This is the first evidence that ODR-10 or any nematode GPCR can form homo-oligomers.
A. Co-immunoprecipitation of a pair of tagged chemoreceptor subunits. B. ODR-10-Rluc co-expressed with SSTR5-GFP2 as a negative control. Following membrane extraction with digitonin and immunoprecipitation with an anti-GFP2 antibody, as described in Materials and Methods, luciferase activity was measured using 5 µM Coelenterazine H with an emission filter of 475±30 nm. Values represent means ± SD of experiments performed on three independent transformants (**denotes significance at P≤0.001), “b” is significantly different from “a”. C. BRET2 ratios measured to test for homo-dimerisation of ODR-10 in intact yeast cells. Values represent means ± SD (n = 3) (**denotes significance at P≤0.001), “b” is significantly different from “a”. Indicated constructs in both A and C were expressed separately, or mixed (+), or co-expressed (/). D. ODR-10 homo-oligomerises in the split-ubiquitin yeast two-hybrid system. The C-terminal half of ubiquitin (Cub) was fused to the C-terminus of the full-length cDNA of odr-10 (ODR-10::Cub). The N-terminal half of ubiquitin (NubG) was fused to the C- termini of full-length cDNA of odr-10 (ODR-10::NubG). The interaction of ODR-10::Cub with pOST1:NubI served as a positive control to ensure the correct topology of the fusion protein. The interaction of ODR-10::Cub with the empty vector (pPR3-STE) served as a negative control. Yeast transformants containing both a Cub fusion and a NubG fusion construct were grown on drop out media (SD -Leu and -Trp) (Figure S2A) and selective medium lacking histidine (SD -Leu, -Trp and -His) containing 35 mM 3-Amino-1, 2, 4-triazole (3-AT). β-galactosidase assays were performed to verify interactions. Cells were spotted as one-tenth dilutions starting at Abs600nm = 1. E. ODR-10 does not hetero-oligomerise with SSTR5 in the split-ubiquitin yeast two-hybrid system. Growth and β-galactosidase activity of yeast cells expressing ODR-10:Cub and SSTR5:NubG fusions. The interaction of SSTR5::NubG with the empty vector (pBT3-STE) served as a negative control. Yeast transformants containing both a Cub fusion and a NubG fusion constructs were grown on drop out media (SD -Leu and -Trp) (Figure S2E) and selective medium lacking histidine (SD -Leu, -Trp and -His) containing 35 mM 3-Amino-1, 2, 4-triazole (3-AT). β-Galactosidase assays were performed to verify interactions. Cells were spotted as one-tenth dilutions starting at Abs600nm = 1.
To determine whether receptor oligomerisation also occurs in intact yeast cells, we used bioluminescence resonance energy transfer (BRET). BRET has previously been used to investigate GPCR oligomerisation in living cells. BRET2 gives a clearer separation than standard BRET between the emission spectra of Renilla luciferase (Rluc) and the green fluorescent protein (GFP2), resulting in much improved signal to noise ratio at the expense of a lower quantum efficiency , , . To compensate for the lower luminescence, we used high-copy number plasmids to express tagged ODR-10 variants under the GAL1 inducible promoter. By monitoring GFP intensity of the transformed cells, we generated a series of samples in which GFP expression levels sequentially increased over background with increasing induction times. BRET2 experiments were conducted at GFP2 levels no more than twofold greater than background, in order to minimise BRET2 due to possible non-specific interactions between ODR-10-Rluc and ODR-10-GFP2, so called “bystander BRET”, due to overexpression (Figure S1).
BRET2 results supported our co-immunoprecipitation conclusions and show that ODR-10 fusion proteins can form homo-oligomers in living yeast cells (Figure 2C). The BRET2 ratio was 0.750±0.038 in yeast cells co-expressing ODR-10-Rluc and ODR-10-GFP2, which was statistically significantly different (P<0.001) from samples, co-expressing ODR-10-Rluc/SSTR5-GFP2 (BRET2 signal, 0.209±0.012) and the mixture of cells separately expressing ODR-10-Rluc and ODR-10-GFP2 (BRET2 ratio 0.193±0.007). Cells expressing neither GFP2 nor Rluc had no measurable BRET2 ratio. The Forster distance of the BRET2 system is approximately 7.5 nm , which means that interacting proteins have to bring the RLuc and GFP2 tags within about 10 nm of each other and be suitably aligned to see an appreciable change in the signal.
As a third, independent, test for the homo-oligomerisation of ODR-10, we used a split-ubiquitin yeast two-hybrid system, which has been developed to assess interactions between membrane proteins , –. In this system, proteins of interest are fused to either the N- or C-terminal moiety of a mutated ubiquitin (Figure 3). The N-terminus of split-ubiquitin includes an Ile to Gly mutation (NubG), which abolishes NubG’s affinity for Cub when expressed in the same cells. The C-terminal moiety of the split-ubiquitin includes an artificial transcription factor domain (Cub-LexA-VP16). Upon in vivo interaction of their respective protein fusion partners, NubG and Cub are forced into close proximity and the interaction can be detected by the release of LexA-VP16 transcription factor, inducing transcriptional activation of growth and colorimetric reporter genes (HIS3, ADE2, and lacZ). We used this system to test for oligomerisation of nematode ORs.
A. Bait fusion proteins were made with the C-terminus of ubiquitin (Cub) linked to the synthetic transcription factor LexA-VP16 at the C-termini of ODR-10, STR-112 and I7 in the pBT3-STE plasmid. The STE2 sequence improves translation of protein constructs. B. Prey protein fusions were constructed with the mutant N-terminal part of ubiquitin (NubG) at the C termini of the SSTR5, STR-112, ODR-10 and I7. If bait and prey interact, NubG and Cub are brought into close proximity, resulting in the reconstitution of functional ubiquitin and release of the LexA-VP16 transcriptional factor, which leads to transcriptional readout, resulting in growth of host yeast cells on the selective medium (SD-L-T-H) or color development in a β-galactosidase assay.
The SignalP 3.0 algorithm predicts that odr-10 does not contain a cleavable N-terminal sequence . Therefore, we fused full-length odr-10 to the C-terminus of ubiquitin in pBT3-STE (ODR-10:Cub) and also to the N-terminus of ubiquitin in pPR3-STE (ODR-10:NubG). The STE2 sequence improves translation of bait and prey sequences. In order to test the homo-oligomerisation of ODR-10, both constructs were co-transformed into the reporter yeast strain (NMY51). In the presence of 35 mM 3-Amino-1, 2, 4-triazole (3-AT), which is required to establish an appropriate level of stringency, ODR-10-Cub interacted with ODR-10-NubG, shown by the growth of this pair on drop out media lacking His and confirmed by β-galactosidase assay (Figure 2D). A negative control expressing ODR-10-Cub with NubG alone (pPR3-STE) showed no growth (Figure 2D). Co-expression of ODR-10-Cub with wild-type Nub I (Ost1-NubI) served as a positive control, which resulted in growth on His-deficient medium and expression of the lacZ reporter as shown in Figure 2D. Growth of yeast expressing ODR-10-Cub and the Ost1-NubI control also confirms that ODR-10 is functional in this yeast system. The bait pTSU2-APP, expressing the type I integral membrane protein amyloid A4 precursor protein (APP) and the prey pNubG-Fe65 expressing the cytosolic protein amyloid beta A4 precursor protein-binding family B member 1 (Fe65) were used as positive controls (Figure 2D). These results, obtained using three independent approaches, provide the first evidence that a nematode chemoreceptor can form homo-oligomers.
ODR-10 can form hetero-oligomers with other olfactory receptors but not with SSTR5
To investigate whether ODR-10 can form hetero-oligomers with other GPCRs, we probed the interaction of ODR-10 with a second C. elegans chemoreceptor, STR-112 and two mammalian receptors, the rat I7 chemoreceptor ,  and the human somatostatin receptor subtype 5 (SSTR5) , . STR-112 is the closest homologue of ODR-10, having 79.6% amino acid identity with it. We used the split-ubiquitin yeast two-hybrid system to test for hetero-oligomerisation of ODR-10 with STR-112. Thus, full-length str-112 was fused to the C-terminus of ubiquitin in pBT3-STE (STR-112:Cub) and also to the N-terminus of ubiquitin in pPR3-STE (STR-112:NubG) as shown in Figure 3. Pairwise interaction was tested, in both ODR-10-Cub/STR-112-NubG and STR-112-Cub/ODR-10-NubG combinations. As shown in Figure 4, ODR-10 interacted with STR-112, demonstrated by growth on drop out medium lacking His as well as by a β-galactosidase induction assay. No growth was observed in negative controls, under the same conditions (Figure 4).
Growth and β-Galactosidase activity of yeast cells expressing various combinations of Cub and NubG fusions. The control plasmids were pPR3-STE and pBT3-STE. Yeast transformants containing both Cub fusion and NubG fusion constructs were grown on drop out media (SD -Leu and -Trp) (Figure S2B) and selective medium lacking histidine (SD -Leu, -Trp and -His) containing 35 mM 3-Amino-1, 2, 4-triazole (3-AT). β-galactosidase assays were performed to verify interactions. Cells were spotted as one-tenth dilutions starting at Abs600nm = 1.
Immunoprecipitation experiments also showed that rat I7 can form heterodimers with ODR-10 (Figure 5A). We confirmed hetero-oligomerisation between ODR-10 and I7 using two other, independent, techniques. Co-expression of ODR-10-Rluc with I7-GFP2 or ODR-10- GFP2 with I7-Rluc gave BRET2 ratios of 0.39±0.12 and 0.40±0.004 respectively, compared with a BRET2 ratio of 0.15±0.004 for ODR-10-Rluc alone, indicating that ODR-10 heterodimerises with I7 (Figure 5B). Furthermore, split-ubiquitin yeast two-hybrid experiments confirmed hetero-oligomerisation of ODR-10 and I7. Pairwise interaction was performed using ODR-10-Cub and I7-NubG combination. As shown in Figure 5C, ODR-10 interacted with I7, observed by the growth on drop out medium lacking His as well as β-galactosidase assay. Immunoprecipitation experiments showed that I7 itself can form homo-oligomers (Figure 6A). Co-expression of I7-Rluc with I7-GFP2 gave a BRET2 ratio of 0.50±0.04 compared with 0.016±0.006 for a post-expression mixture (Figure 6B), which is statistically significant (P≤0.01). Furthermore, rat I7 scored positive for homo-oligomerisation in the split-ubiquitin yeast two-hybrid assay (Figure 6C) both by growth on drop out media lacking His, and by β-galactosidase assay. This is consistent with the finding of Wade et al , that hOR1740, a human helional receptor, can form functional homodimers.
A. Co-immunoprecipitation of pairs of tagged chemoreceptor subunits. Values represent means ± SD of experiments performed in triplicate with three independent transformants for each condition (**denotes significance at P≤0.001), “b” is significantly different from “a”. B. BRET2 ratios measured to test for hetero-dimerisation of ODR-10 and I7 in intact yeast cells. Values represent means ± SD (n = 3) (**denotes significance at P≤0.002), “b” is significantly different from “a”. Indicated constructs in both A and B were expressed separately, or mixed (+), or co-expressed (/). C. ODR-10 hetero-oligomerises with I7 in the split-ubiquitin yeast two-hybrid system. Growth and β-galactosidase activity of yeast cells expressing ODR-10:Cub and I7:NubG fusions. Yeast transformants containing both Cub fusion and NubG fusion constructs were grown on drop out media (SD -Leu and -Trp) (Figure S2C) and selective medium lacking histidine (SD -Leu, -Trp and -His) containing 35 mM 3-Amino-1, 2, 4-triazole (3-AT). β-galactosidase assays were performed to verify interactions. Cells were spotted as one-tenth dilutions starting at Abs600nm = 1.
A. Co-immunoprecipitation of a pair of tagged chemoreceptor subunits. Values represent means ± SD of experiments performed in triplicate with three independent transformants for each condition (**denotes significance at P≤0.001), “b” is significantly different from “a”. B. BRET2 ratios measured to test for homo-oligomerisation of I7 in intact yeast cells. Values represent means ± SD of experiments performed in triplicate with three independent transformants for each condition. (*denotes significance at P≤0.01). Indicated constructs in both A and B were expressed separately, or mixed (+), or co-expressed (/). C. I7 homo-oligomerises in the split-ubiquitin yeast two-hybrid system. Growth and β-galactosidase activity of yeast cells expressing I7:Cub and I7:NubG fusions. The interaction of I7::Cub with the empty vector (pPR3-STE) served as a negative control. Yeast transformants containing both a Cub fusion and a NubG fusion constructs were grown on drop out media (SD -Leu and -Trp) (Figure S2D) and selective medium lacking histidine (SD -Leu, -Trp and -His) containing 35 mM 3-Amino-1,2,4-triazole (3-AT). β-galactosidase assays were performed to verify interactions. Cells were spotted as one-tenth dilutions starting at Abs600nm = 1.
Given the evolutionary distance separating nematodes and mammals and their odorant receptors , we were somewhat surprised that ODR-10 and I7 interacted It seems plausible, although we have not shown it, that ODR-10 oligomers are functional. It is also conceivable that ODR-10 may form functional oligomers with other nematode ORs, such as STR-112. However, ODR-10 and I7 are never co-expressed in nature and their oligomerisation could only be meaningful in a structural, rather than a functional sense.
We therefore also used the yeast two-hybrid system to test whether ODR-10 can interact with a more distantly related, non-olfactory, mammalian GPCR. For this purpose we chose the human somatostatin receptor, SSTR5, a class A GPCR. We tested pairwise interaction between ODR-10-Cub and SSTR5-NubG using the split-ubiquitin yeast two-hybrid system. As shown in Figure 2E, ODR-10 did not interact with SSTR5, demonstrated by lack of growth on drop out media lacking His, and lack of β-galactosidase expression. It is possible that the enhanced BRET signals observed, whilst not being completely non-specific, only occur at the receptor concentrations achieved in the heterologous yeast system. It remains to be seen whether such interactions can be observed in the natural environment of a nematode OSN.
Three independent lines of evidence show that, in the heterologous yeast system, the C. elegans olfactory receptor ODR-10 forms homo-oligomers. Homo-oligomerisation has been previously described for mammalian olfactory receptors . ODR-10 can also oligomerise with a closely related C. elegans chemosensory receptor, and even with a mammalian olfactory receptor. In contrast, we saw no evidence for hetero-oligomerisation between ODR-10 and the human peptide receptor SSTR5. However, we cannot rule out the possibility that ODR-10 might interact with some non-chemosensory GPCRs. One previous study found that a single mammalian olfactory receptor, screened indirectly for interactions with 42 distinct GPCR subtypes, interacted with only three purinergic receptors . These interactions appeared to be receptor specific, as other olfactory receptors tested did not interact with the purinergic receptors. Vertebrate olfactory neurons typically express only one or two receptors per neuron , . In these systems, perception of odours is processed in higher order brain centres by simultaneously analysing the inputs of thousands of neurons . C. elegans has hundreds of chemoreceptor genes, but only 32 chemosensory neurons, implying that a single neuron expresses many different chemoreceptor genes , . Our observations raise the possibility that C. elegans chemosensory receptors expressed in the same sensory neuron in vivo could form heterodimers, which would have the potential to increase the functional repertoire of individual OSNs. However, we emphasise that we have no evidence that such interactions occur in vivo, nor that they are functional even in the yeast system used here. It would be interesting to search for hetero-oligomerisation in vivo, by transforming C. elegans with neuronally-targetted pairs of BRET-tagged odorant receptors.
BRET2 results showed that specific signals obtained from a series of low level expression of tagged ODR-10 samples showed that interactions between ODR-10 were specific and not collisional interactions due to over-expression. Tested yeast cells were induced for expressing tagged ODR-10 proteins for different times (between 0 to 72 hours) at 15°C in order to achieve different levels of ODR-10 expression as indicated by tagged GFP levels from 1 to 12-fold over the untransformed cells. Only samples with GFP2 levels≤2 fold greater than controlled cells (to the left of the vertical line) were used for oligomerisation studies. Energy transfer measurements were performed in living cells by adding 5 µM DeepBlueC and measured light emissions in a dual wavelength microplate reader with Rluc and GFP filter settings as described in the Methods. Values represent means ± SD of two independent experiments.
Positive controls for Figures 2, 4, 5 and 6. Yeast transformants containing both a Cub fusion and a NubG fusion construct were grown on drop out media (SD -Leu and -Trp) to test the presence of both constructs in yeast cells. Cells were spotted as one-tenth dilutions starting at Abs600nm = 1.
The authors gratefully acknowledge Dr Kevin Pfleger and Dr Peter East for advice and critical review of the manuscript.
Conceived and designed the experiments: MT CL MD ST HD AA. Performed the experiments: MT CL MD. Analyzed the data: MT CL. Contributed reagents/materials/analysis tools: MT CL. Wrote the paper: MT ST AA.
- 1. Gurevich VV, Gurevich EV (2008) How and why do GPCRs dimerize? Trends in Pharmacological Sciences 29: 234–240.
- 2. Marinissen MJ, Gutkind JS (2001) G-protein coupled receptors and signaling networks: emerging paradigms. Trends in Pharmacological Sciences 22: 368–376.
- 3. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA (2001) Oligomerisation of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA 98: 343–348.
- 4. George SR, O’Dowd BF, Lee SP (2002) G-protein coupled receptor oligomerisation and its potential for drug discovery. Nat Rev Drug Discov 1: 808–820.
- 5. Kroeger KM, Pfleger KD, Eidne KA (2003) G-protein coupled receptor oligomerisation in neuroendocrine pathways. Front Neuroendocrinol 24: 254–278.
- 6. Milligan G (2004) G-protein coupled receptor dimerisation: function and ligand pharmacology. Mol Pharmacol 66: 1–7.
- 7. Bulenger S, Marullo S, Bouvier M (2005) Emerging role of homo- and heterodimerisation in G-protein coupled receptor biosynthesis and maturation. Trends in Pharmacological Sciences 26: 131–137.
- 8. Milligan G (2008) A day in the life of a G-protein coupled receptor: the contribution to function of G-protein coupled receptor dimerisation. Br J Pharmacol 153 Suppl 1S216–229.
- 9. Fuxe K, Ferre S, Canals M, Torvinen M, Terasmaa A, et al. (2005) Adenosine A(2A) and dopamine D-2 heteromeric receptor complexes and their function. Journal of Molecular Neuroscience 26: 209–219.
- 10. del Burgo LS, Milligan G (2010) Heterodimerisation of G-protein coupled receptors: implications for drug design and ligand screening. Expert Opinion on Drug Discovery 5: 461–474.
- 11. Prinster SC, Holmqvist TG, Hall RA (2006) alpha(2C)-Adrenergic receptors exhibit enhanced surface expression and signaling upon association with beta(2)-adrenergic receptors. Journal of Pharmacology and Experimental Therapeutics 318: 974–981.
- 12. Uberti MA, Hague C, Oller H, Minneman KP, Hall RA (2005) Heterodimerisation with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. J Pharmacol Exp Ther 313: 16–23.
- 13. Ranadive SA, Ersoy B, Favre H, Cheung CC, Rosenthal SM, et al. (2009) Identification, characterisation and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Clin Endocrinol (Oxf) 71: 388–393.
- 14. Marshall FH, Jones KA, Kaupmann K, Bettler B (1999) GABAB receptors - the first 7TM heterodimers. Trends Pharmacol Sci 20: 396–399.
- 15. Lavoie C, Mercier JF, Salahpour A, Umapathy D, Breit A, et al. (2002) Beta 1/beta 2-adrenergic receptor heterodimerisation regulates beta 2-adrenergic receptor internalisation and ERK signaling efficacy. J Biol Chem 277: 35402–35410.
- 16. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, et al. (2007) D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 104: 654–659.
- 17. Bargmann CI (2006) Comparative chemosensation from receptors to ecology. Nature 444: 295–301.
- 18. Vassar R, Ngai J, Axel R (1993) Spatial segregation of odorant receptor expression in the mammalian olfactory epithelium. Cell 74: 309–318.
- 19. Goldman AL, van Naters WV, Lessing D, Warr CG, Carlson JR (2005) Coexpression of two functional odor receptors in one neuron. Neuron 45: 661–666.
- 20. Nelson G, Hoon MA, Chandrashekar J, Zhang YF, Ryba NJP, et al. (2001) Mammalian sweet taste receptors. Cell 106: 381–390.
- 21. Li XD (2009) T1R receptors mediate mammalian sweet and umami taste. American Journal of Clinical Nutrition 90: 733s–737s.
- 22. Robertson HM, Thomas JH (2006) The putative chemoreceptor families of C. elegans. WormBook: 1–12.
- 23. Bargmann CI (1993) Genetic and cellular analysis of behavior in C. elegans. Annual Review of Neuroscience 16: 47–71.
- 24. Troemel ER, Chou JH, Dwyer ND, Colbert HA, Bargmann CI (1995) Divergent seven transmembrane receptors are candidate chemosensory receptors in C. elegans. Cell 83: 207–218.
- 25. Gray JM, Karow DS, Lu H, Chang AJ, Chang JS, et al. (2004) Oxygen sensation and social feeding mediated by a C. elegans guanylate cyclase homologue. Nature 430: 317–322.
- 26. Sengupta P, Chou JH, Bargmann CI (1996) odr-10 encodes a seven transmembrane domain olfactory receptor required for responses to the odorant diacetyl. Cell 84: 899–909.
- 27. Zhang Y, Chou JH, Bradley J, Bargmann CI, Zinn K (1997) The Caenorhabditis elegans seven-transmembrane protein ODR-10 functions as an odorant receptor in mammalian cells. Proc Natl Acad Sci USA 94: 12162–12167.
- 28. Roayaie K, Crump JG, Sagasti A, Bargmann CI (1998) The G alpha protein ODR-3 mediates olfactory and nociceptive function and controls cilium morphogenesis in C-elegans olfactory neurons. Neuron 20: 55–67.
- 29. Cottet M, Faklaris O, Maurel D, Scholler P, Doumazane E, et al. (2012) BRET and Time-resolved FRET strategy to study GPCR oligomerisation: from cell lines toward native tissues. Front Endocrinol (Lausanne) 3: 92.
- 30. Rios CD, Jordan BA, Gomes I, Devi LA (2001) G-protein coupled receptor dimerisation: modulation of receptor function. Pharmacol Ther 92: 71–87.
- 31. Angers S, Salahpour A, Bouvier M (2002) Dimerisation: an emerging concept for G-protein coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42: 409–435.
- 32. Szidonya L, Cserzo M, Hunyady L (2008) Dimerisation and oligomerisation of G-protein coupled receptors: debated structures with established and emerging functions. Journal of Endocrinology 196: 435–453.
- 33. Zhao HQ, Ivic L, Otaki JM, Hashimoto M, Mikoshiba K, et al. (1998) Functional expression of a mammalian odorant receptor. Science 279: 237–242.
- 34. Iguchi Y, Ishii J, Nakayama H, Ishikura A, Izawa K, et al. (2010) Control of signalling properties of human somatostatin receptor subtype-5 by additional signal sequences on its amino-terminus in yeast. Journal of Biochemistry 147: 875–884.
- 35. Dacres H, Wang J, Leitch V, Horne I, Anderson AR, et al. (2011) Greatly enhanced detection of a volatile ligand at femtomolar levels using bioluminescence resonance energy transfer (BRET). Biosensors & Bioelectronics 29: 119–124.
- 36. Gietz D, St Jean A, Woods RA, Schiestl RH (1992) Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20: 1425.
- 37. Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, et al. (2002) Monitoring of ligand-independent dimerisation and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 277: 21522–21528.
- 38. Issad T, Jockers R (2006) Bioluminescence resonance energy transfer to monitor protein-protein interactions. Methods Mol Biol 332: 195–209.
- 39. Iyer K, Burkle L, Auerbach D, Thaminy S, Dinkel M, et al.. (2005) Utilizing the split-ubiquitin membrane yeast two-hybrid system to identify protein-protein interactions of integral membrane proteins. Science’s STKE : signal transduction knowledge environment 2005: p. pl3.
- 40. Mentesana PE, Dosil M, Konopka JB (2002) Functional assays for mammalian G-protein-coupled receptors in yeast. G Protein Pathways Part B: G Proteins and Their Regulators 344: 92–111.
- 41. Dowell SJ, Brown AJ (2002) Yeast assays for G-protein coupled receptors. Receptors & Channels 8: 343–352.
- 42. Fukutani Y, Ishii J, Noguchi K, Kondo A, Yohda M (2012) An improved bioluminescence-based signaling assay for odor sensing with a yeast expressing a chimeric olfactory receptor. Biotechnology and Bioengineering 109: 3143–3151.
- 43. Radhika V, Proikas-Cezanne T, Jayaraman M, Onesime D, Ha JH, et al. (2007) Chemical sensing of DNT by engineered olfactory yeast strain. Nature Chemical Biology 3: 325–330.
- 44. Sanz G, Persuy MA, Vidic J, Wafe F, Longin C, et al.. (2009) European Chemorecepetion Research Organization XIX Congress Villasimius, Italy.
- 45. Gines S, Hillion J, Torvinen M, Le Crom S, Casado V, et al. (2000) Dopamine D-1 and adenosine A(1) receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 97: 8606–8611.
- 46. Zeng FY, Wess J (1999) Identification and molecular characterization of m3 muscarinic receptor dimers. Journal of Biological Chemistry 274: 19487–19497.
- 47. Devi LA (2001) Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends in Pharmacological Sciences 22: 532–537.
- 48. Yoshioka K, Saitoh O, Nakata H (2001) Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci USA 98: 7617–7622.
- 49. Hillion J, Canals M, Torvinen M, Casado V, Scott R, et al. (2002) Coaggregation, cointernalisation, and codesensitisation of adenosine A(2A) receptors and dopamine D-2 receptors. Journal of Biological Chemistry 277: 18091–18097.
- 50. Xu JG, He JQ, Castleberry AM, Balasubramanian S, Lau AG, et al. (2003) Hetero-dimerisation of alpha(2A)- and beta(1)-adrenergic receptors. Journal of Biological Chemistry 278: 10770–10777.
- 51. Xu Y, Piston DW, Johnson CH (1999) A bioluminescence resonance energy transfer (BRET) system: Application to interacting circadian clock proteins. Proc Natl Acad Sci USA 96: 151–156.
- 52. Ramsay D, Kellett E, McVey M, Rees S, Milligan G (2002) Homo- and hetero-oligomeric interactions between G-protein coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochemical Journal 365: 429–440.
- 53. Dacres H, Wang J, Dumancic MM, Trowell SC (2010) Experimental determination of the forster distance for two commonly used bioluminescent resonance energy transfer pairs. Analytical Chemistry 82: 432–435.
- 54. Johnsson N, Varshavsky A (1994) Split Ubiquitin as a Sensor of Protein Interactions in-Vivo. Proc Natl Acad Sci USA 91: 10340–10344.
- 55. Stagljar I, Korostensky C, Johnsson N, te Heesen S (1998) A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. Proc Natl Acad Sci USA 95: 5187–5192.
- 56. Pandey S, Assmann SM (2004) The Arabidopsis putative G-protein coupled receptor GCR1 interacts with the G protein alpha subunit GPA1 and regulates abscisic acid signaling. Plant Cell 16: 1616–1632.
- 57. Okagaki LH, Wang YN, Ballou ER, O’Meara TR, Bahn YS, et al. (2011) Cryptococcal titan cell formation is regulated by G-protein signaling in response to multiple stimuli. Eukaryotic Cell 10: 1306–1316.
- 58. Pandey P, Harbinder S (2012) The Caenorhabditis elegans D2-like dopamine receptor DOP-2 physically interacts with GPA-14, a Galphai subunit. J Mol Signal 7: 3.
- 59. Emanuelsson O, Brunak S, von Heijne G, Nielsen H (2007) Locating proteins in the cell using TargetP, SignalP and related tools. Nature Protocols 2: 953–971.
- 60. Araneda RC, Kini AD, Firestein S (2000) The molecular receptive range of an odorant receptor. Nature Neuroscience 3: 1248–1255.
- 61. Ocarroll AM, Raynor K, Lolait SJ, Reisine T (1994) Characterisation of cloned human somatostatin receptor SSTR5. Molecular Pharmacology 46: 291–298.
- 62. Wade F, Espagne A, Persuy MA, Vidic J, Monnerie R, et al. (2011) Relationship between homo-oligomerisation of a mammalian olfactory receptor and its activation state demonstrated by bioluminescence resonance energy transfer. Journal of Biological Chemistry 286: 15252–15259.
- 63. Fredriksson R, Schioth HB (2005) The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 67: 1414–1425.
- 64. Bush CF, Jones SV, Lyle AN, Minneman KP, Ressler KJ, et al. (2007) Specificity of olfactory receptor interactions with other G-protein coupled receptors. Journal of Biological Chemistry 282: 19042–19051.
- 65. Mori K, Nagao H, Yoshihara Y (1999) The olfactory bulb: Coding and processing of odor molecule information. Science 286: 711–715.
- 66. McCarroll SA, Li H, Bargmann CI (2005) Identification of transcriptional regulatory elements in chemosensory receptor genes by probabilistic segmentation. Curr Biol 15: 347–352.